Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Correlation between MACC1 expression and the clinicopathologic characteristics of the breast cancer patients

From: Overexpression of MACC1 and Its significance in human Breast Cancer Progression

Characteristics

Cohort 1

Cohort 2

 

MACC1 expression

MACC1 expression

 

Low

High

P-value

Low

High

P-value

Age

      

 ≤45

44

51

0.647

29

49

0.504

 >45

65

85

 

45

62

 

Menopausal status

      

 Premenopausal

56

60

0.799

   

 Postmenopausal

51

51

    

Clinical stage

      

 I

43

38

0.001

19

2

<0.001

 II

45

46

 

37

43

 

 III

15

25

 

14

45

 

 IV

5

28

 

4

21

 

T classification

      

 T1

61

49

0.019

23

13

<0.001

 T2

39

68

 

39

53

 

 T3

6

12

 

11

30

 

 T4

3

7

 

1

15

 

N classification

      

 N0

67

68

0.050

44

26

<0.001

 N1

25

26

 

24

54

 

 N2

12

29

 

4

26

 

 N3

5

13

 

2

5

 

Distant metastasis

      

 Yes

104

108

<0.001

0

8

0.022

 No

5

28

 

74

103

 

Estrogen receptor

      

 Positive

79

95

0.653

36

65

0.185

 Negative

30

41

 

38

46

 

Progesterone receptor

      

 Positive

63

83

0.990

43

67

0.760

 Negative

32

42

 

31

44

 

Her2

      

 Positive

21

22

0.862

8

13

0.480

 Negative

71

79

 

36

41

 

Endocrine therapy

      

 tamoxifen

62

60

0.614

   

 No treatment

45

50

    
Back to article page

Cell & Bioscience

ISSN: 2045-3701

Contact us